MK-4256

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameMK-4256
Drug Alias NameMK-4256
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 3 agonists
TargetsSomatostatin receptor 3
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A